Search In this Thesis
   Search In this Thesis  
العنوان
Hyperprolactinemia \
المؤلف
El-Sharkawy, Emad Ahmed.
هيئة الاعداد
باحث / عماد احمد الشرقاوي
مشرف / محمد مصطفى الشافعي
مناقش / عماد احمد الشرقاوي
مناقش / محمد مصطفى الشافعي
الموضوع
Hyperprolactinemia - therapy.
تاريخ النشر
1984.
عدد الصفحات
177 p. :
اللغة
الإنجليزية
الدرجة
ماجستير
التخصص
أمراض النساء والتوليد
تاريخ الإجازة
1/1/1984
مكان الإجازة
جامعة المنصورة - كلية الطب - النساء والتوليد
الفهرس
Only 14 pages are availabe for public view

from 188

from 188

Abstract

Prolactin is secreted by the anterior pituitary under permanent inhibitory control from the hypothalamus. The most important hypothalamic inhibiting factor is almost certainly dopamine itself, and the principal physiologic effect of :PEL in human females is the initiation of lactation. Hyperprolactinemia may occur in association with pituitary tumors although they are often small and may present difficulties in diagnosis. other causes of hyperprolactinemia include hypothalamic disease, or disruption of the hypothalamic-hypophyseal stalk, primary hypothyroidism and the taking of certain drugs which act either by blocking dopamine receptors at the pituitary (e.g phenothiazines, benzamides ,metoclopram and sulpiride), or by depleting the stores of dopamine (e.g. reserpine and methyl dopa) or through non dopamine mechanisms at the pituitary level (e.g. estrogens and thyroid releasing hormone). A patient with hyperprolactinemia may present a broad spectrum of symptoms.